000			01590 a2200457 4500
005			20250512012840.0
264		0	_c19890913
008			198909s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aAzuma, E
245	0	0	_aUse of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cSep 1989
300			_a1524-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBone Marrow _ximmunology
650	0	4	_aBone Marrow Transplantation
650	0	4	_aClone Cells _ximmunology
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aFemale
650	0	4	_aGraft Rejection
650	0	4	_aGraft Survival
650	0	4	_aGraft vs Host Disease _xprevention & control
650	0	4	_aImmunity, Innate _xradiation effects
650	0	4	_aImmunization, Passive
650	0	4	_aInterleukin-1 _xpharmacology
650	0	4	_aIsoantigens _xgenetics
650	0	4	_aKiller Cells, Natural _xclassification
650	0	4	_aLymphocyte Activation _xradiation effects
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aMice, Inbred C57BL
650	0	4	_aPhenotype
650	0	4	_aRadiation Chimera
650	0	4	_aRecombinant Proteins _xpharmacology
700	1		_aYamamoto, H
700	1		_aKaplan, J
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 143 _gno. 5 _gp. 1524-9
999			_c2674291 _d2674291